Treatment of post-prandial hyperinsulinemia and hypoglycemia after bariatric surgery

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10711067
APP PUB NO 20180037658A1
SERIAL NO

15555608

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates, in general, to methods of treating or preventing post-prandial hypoglycemia after gastric bypass surgery using a negative modulator antibody that binds to the insulin receptor and modulates the action of insulin at the insulin receptor.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
XOMA (US) LLC2910 SEVENTH STREET BERKELEY CA 94710

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Johnson, Kirk W Moraga, US 49 4040
Nath, Rajneesh Los Altos Hills, US 1 0
Rubin, Paul San Francisco, US 9 358

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 14, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 14, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00